CSBR
CSBR
NASDAQ · Life Sciences Tools & Services

Champions Oncology Inc

$6.55
+0.02 (+0.31%)
As of Feb 8, 2:12 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +349.6% upside
Low Target $20.89
Average Target $29.45
High Target $33.06
Current Price $6.55
Current
$6.55
Target
$29.45
$20.89 $29.45 avg $33.06
Scenario Analysis
Bear Case
$20.89
218.9%
Low target
Base Case
$29.45
+349.6%
Avg target
Bull Case
$33.06
+404.7%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$29.71
-78.0% from high
52-Week Low
$14.12
+-53.6% from low
Target vs 52W High
$29.45
-0.9% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 33 82% $369.21 -32.0%
DHR
Danaher Corp
Strong Buy 31 87% $158.11 -27.0%
A
Agilent Technologies Inc
Buy 29 72% $64.69 -50.1%
IQV
Iqvia Holdings Inc
Strong Buy 30 80% $82.96 -55.8%
MTD
Mettler-Toledo International
Hold 21 43% $170.43 -87.6%
WAT
Waters Corp
Buy 25 56% $189.60 -50.3%
ILMN
Illumina Inc
Hold 26 50% $169.36 +41.5%
WST
West Pharmaceutical Services
Strong Buy 23 78% $136.24 -45.3%